Key result
Myocardial T2 mapping values were significantly elevated in acute (59 ± 9 msec) and chronic (53 ± 5 msec) myocarditis compared to healthy controls (48 ± 3 msec).
Why the study?
Does quantitative T2 mapping by CMR differentiate between acute myocarditis, chronic myocarditis, and healthy myocardium?
Cross-Sectional (n=80)
Does quantitative T2 mapping by CMR differentiate between acute myocarditis, chronic myocarditis, and healthy myocardium?
Absolute Event Rate: 59% vs 48%
p-value: p=<0.0001
Quantitative T2 mapping by CMR can accurately detect myocardial inflammation and discriminate between acute and chronic stages of myocarditis.
T2 mapping may aid myocarditis diagnosis amid artifacts; leaves open prospective validation before practice change.
Cardiac magnetic resonance (CMR) increasingly adds to clinical conformation of the diagnosis in patients with suspected myocarditis. The proposed Lake Louise Consensus Criteria ("any-two" approach) can separate from chronic forms of myocardial inflammation. However, both global enhancement ratio (GRE) and T2-weighted imaging are underutilized, due to poor reproducibility and high susceptibility to artefacts. T1 and T2 mapping by CMR projects tissue-dependent relaxation times. T2 mapping has been recently proposed as a robust and accurate technique to identify areas of focal myocardial oedema. Our aim was to investigate the value of quantitative T2 values in discrimination between health and disease, and separation between active/acute myocarditis and chronic convalescent stage of the disease. Twenty-four patients with acute presentation of viral myocarditis and twenty-three subjects in clinical convalescence were recruited. Thirty-three healthy subjects were served as controls. All subjects underwent CMR study for routine assessment of myocardial oedema, function and scar by at 3-Tesla scanner. T2 values were acquired in midventricular short-axis slice (mSAX) using GraSE sequence. We examined regional T2 values in patients and controls. T2 values are presented as an average of the six segments per mSAX. Secondly we investigated the differences between visually involved and remote myocardium (involved myocardium = areas by LGE, remote = areas with no LGE) Patients with acute myocarditis and chronic myocarditis showed significantly raised T2 values [controls vs. acute vs. chronic myocarditis, T2 myocardium (msec): 48 ± 3 vs. 59 ± 9 vs. 53 ± 5, p < 0.0001). Compared to controls, T2 values in remote myocardium were significantly different for acute myocarditis only (T2, msec: 48 ± 3 vs. 51 ± 5 vs. 49 ± 2, p < 0.01), whereas T2 values in involved myocardium differed between all groups (T2, msec: 48 ± 3 vs. 69 ± 13 vs. 57 ± 8, p < 0.0001]. Using T2 values of complete mSAX or involved were identified as the independent discriminators between active and chronic myocarditis. T2 values were concordant with T2 oedema ratio (T2 involved, r = 0.42, p < 0.0001) and with native T1 (r = 0.55, p < 0.001). We demonstrate that quantitative T2 values are increased in patients with myocarditis. We further demonstrate that average mSAX and involved T2 values can discriminate between acute and chronic stage of the disease.
No takes yet. Share an insight, caveat, or question.
Hinojar et al. (2014) conducted a cross-sectional in Acute and chronic myocarditis (n=80). Myocardial T2 mapping vs. Healthy controls was evaluated on Global myocardial T2 values (msec) (p=<0.0001). Myocardial T2 mapping values were significantly elevated in acute (59 ± 9 msec) and chronic (53 ± 5 msec) myocarditis compared to healthy controls (48 ± 3 msec).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: